Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BGB-B3227 |
Synonyms | |
Therapy Description |
BGB-B3227 is an NK-cell engager targeting MUC1 and CD16A, which potentially induces antibody-dependent cellular cytotoxicity in tumor cells expressing MUC1 and antitumor activity (Cancer Res (2025) 85 (8_Supplement_1): 1789). |